Derek Gregory Batcheller

Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden.

Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden.

Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden.

Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden.

ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden.

Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.

CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden.

PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden.